Literature DB >> 6661161

Reflex effects evoked from the parietal pericardium in the dog: comparison with responses from the visceral pericardium.

P N Nolan, D E Luk, J Staszewska-Barczak.   

Abstract

Experiments were performed on anaesthetized, open-chest dogs to determine the reflex effects on systemic blood pressure and heart rate produced by stimulation of the parietal pericardium with bradykinin and nicotine, and to compare these effects with those evoked by application of these substances to the visceral pericardium (epicardium) of the left ventricle. Bradykinin (0.01-6.0 micrograms) elicited reflex increases in blood pressure and heart rate when applied either to the parietal pericardium or to the ventricular epicardium; the responses evoked from both sites were dose-dependent from the threshold of 0.01 micrograms to a maximum at 1.0 micrograms of bradykinin. The reflex effects of bradykinin were not affected by either vagotomy or phrenic nerve section, but were suppressed by bilateral sectioning of the upper thoracic (T1-T4) white rami communicantes and stellectomy. In contrast to bradykinin, nicotine (20-100 micrograms) failed to produce any change in blood pressure and heart rate when applied to the parietal pericardium and evoked depressor responses when applied to the epicardium of the left ventricle; these depressor effects of nicotine were abolished by vagotomy. The results indicate that sympathetic, but not vagal, afferent endings innervating the parietal pericardium are susceptible to chemical stimulation. Bradykinin is a powerful algesic agent and is formed and released locally during inflammation. We suggest, therefore, that the pericardial sympathetic pressor reflex is nociceptive in nature and can be activated when kinin formation occurs during pericardial inflammation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661161     DOI: 10.1007/bf01907212

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  18 in total

1.  Competitive and non-competitive inhibition of bradykinin on the guinea-pig ileum.

Authors:  J Garcia Leme; M Rocha E Silva
Journal:  Br J Pharmacol Chemother       Date:  1965-08

2.  Distribution and responses of the cardiac sympathetic receptors to mechanically induced circulatory changes.

Authors:  H Ueda; Y Uchida; K Kamisaka
Journal:  Jpn Heart J       Date:  1969-01

3.  Search for a cardiac nociceptor: stimulation by bradykinin of sympathetic afferent nerve endings in the heart of the cat.

Authors:  D G Baker; H M Coleridge; J C Coleridge; T Nerdrum
Journal:  J Physiol       Date:  1980-09       Impact factor: 5.182

4.  Contrasting reflexes evoked by chemical activation of cardiac afferent nerves.

Authors:  K A Reimann; L C Weaver
Journal:  Am J Physiol       Date:  1980-09

Review 5.  The normal pericardium.

Authors:  J P Holt
Journal:  Am J Cardiol       Date:  1970-11       Impact factor: 2.778

6.  Action potentials in fibres from receptors in the epicardium and myocardium of the dog's left ventricle.

Authors:  P Sleight; J G Widdicombe
Journal:  J Physiol       Date:  1965-11       Impact factor: 5.182

7.  Action potentials in afferent fibres from pericardial mechanoreceptors in the dog.

Authors:  P Sleight; J G Widdicombe
Journal:  J Physiol       Date:  1965-11       Impact factor: 5.182

8.  An excitatory nociceptive cardiac reflex elicited by bradykinin and potentiated by prostaglandins and myocardial ischaemia.

Authors:  J Staszewka-Barczak; S H Ferreira; J R Vane
Journal:  Cardiovasc Res       Date:  1976-05       Impact factor: 10.787

9.  Cardiac, aortic, pericardial, and pulmonary receptors in the dog.

Authors:  S R Peters; D R Kostreva; J A Armour; E J Zuperku; F O Igler; R L Coon; J P Kampine
Journal:  Cardiology       Date:  1980       Impact factor: 1.869

10.  Sympathetic cardiovascular reflex initiated by bradykinin-induced stimulation of cardiac pain receptors in the dog.

Authors:  J Staszewska-Barczak; G J Dusting
Journal:  Clin Exp Pharmacol Physiol       Date:  1977 Sep-Oct       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.